EARNING RECAP

Trade Desk

#TTD 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $1.09 est. 80c $160.5M est. $147.65M +31.39% ($197.73 closing price) $200.15 $173.50 record high; says 2018 is Foundational year as they launched the biggest product :Next wave" 2018 revenue grew 55% compared to 52% in 2017; sees 2019 revenue at least $637M est. $616.73M; customer retention still at 95%
Q3 65c est. 50c $118.8M est. $117.37M +.30% ($122.57 closing price) $130.96 $110.20 sees Q4 revenue $147M, consensus $144.77M; raises FY18 revenue view to at least $464M from $456M Consensus $460.34M
Q2 60c est. 44c $112.3M est. $104.02M +37.13% ($127.93 closing price) $130.84 $112.27 record high; sees Q3 revenue $116M est. $109.14M; sees FY18 revenue at least $456M est. $436.54M
Q1 34c est. 10c $85.7M est. $72.23M +43.39% ($75.61 closing price) $75.80 $67.31 record high* sees Q2 revenue $85.7M est. $72.23M; raises FY18 revenue at least $433M est. $403.96M
#TTD 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 54c est. 43c $102.6M est. $101.7M +23.84 ($59.94 closing price) $60.19 $54.69
Q3 35c est. 27c $79.4M est. $76.88M -13.98% ($50.99 closing) $53.47 $49.25 guides Q4 revenue $101M est. $101.64M/ FY17 revenue $306M est. $304.69M

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.